Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Fibromyalgia Impact Questionnaire× | Hroniskas sirds mazspējas aptauja× | |
|---|---|---|
| Nozare | Veselības iznākumi | Veselības iznākumi |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1991 | 2000 |
| Autors≠ | Cynthia S. Burckhardt et al. | Luc Guyonnet et al. |
| Tips≠ | Self-report symptom and functional impairment questionnaire | Self-report quality of life questionnaire |
| Pirmavots≠ | Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735. link ↗ | Guyonnet, S., Vellas, B., Garry, P. J., & Albarede, J. L. (2000). The Chronic Heart Failure Questionnaire: A pilot study of validity, reliability, and responsiveness. Journal of Cardiac Failure, 6(1), 21-26. link ↗ |
| Citi nosaukumi | FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire | CHQ, Heart Failure Quality of Life, Chronic Heart Failure QoL |
| Saistītās | 4 | 4 |
| Kopsavilkums≠ | The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice. | The CHQ is a disease-specific quality of life measure for chronic heart failure (CHF). Developed by Luc Guyonnet and colleagues in 2000, this 20-item questionnaire assesses how heart failure affects dyspnea, fatigue, emotional function, and activity limitation. It is used in heart failure clinical trials and research to quantify patient-experienced burden and treatment benefit. |
| ScholarGateDatu kopa ↗ |
|
|